13vPnC Multidose Vial Safety, Tolerability and Immunogenicity Study in Healthy Infants.

NCT01964716 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
500
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer